Virbac Australia

Discover Virbac

About Virbac Australia

Virbac (Australia) Pty Ltd is an animal health company passionate about serving the needs of livestock producers and pet owners in Australia. Our large team of over 200 personnel develops, produces and sells a wide range of products for sheep, cattle, cats, dogs and horses. Virbac is one of the few animal health companies in Australia that has invested in dedicated R&D and significant manufacturing capability to serve the needs of our Australian customers.

Virbac

Virbac (Australia) Pty Ltd is part of the Virbac group which was founded in 1968 in Carros, close to Nice, by veterinarian Pierre-Richard Dick. The ownership structure of the company has not changed and is still in the control of the founder’s family. Another differentiating aspect of the company, is that it is dedicated exclusively to animal health. This stability, independence and focus have been cornerstones of the group which today has grown to be a truly global company selling into over 100 countries.

Virbac started in Australia in 1987 as a joint-venture with only 11 staff. Since then it has grown organically and through acquisition to become one of the top 10 animal health companies in Australia. Today Virbac Australia’s sales turnover exceeds AUD100 M.

Virbac has R&D centres in 8 countries including Australia. The size of the Australian market allows Virbac to maintain a dedicated team and 3 laboratories in Sydney. While the focus is on parasiticides and vaccines for ruminants, the R&D team in Australia also has a growing interest in nutrition and welfare. Having manufacturing located physically close to R&D allows for seamless transfer of new products.

Virbac is proud to be a local manufacturer, employing more than 100 people in manufacturing at three Australian sites. Its production facilities located in Crookwell in rural NSW, Penrith and Macquarie Park in Sydney hold GMP Licenses issued by the APVMA to manufacture veterinary and animal health products. The Macquarie Park site is also accredited by the FDA.

Virbac facility

Virbac’s diverse range of products means you can usually rely on Virbac to have a solution to most animal health problems. This range of products includes some well-known brands:

Virbac manufactures and sells many unique products that are unmatched by competitors, such as: CYDECTIN EWEGUARD® and WEANERGUARD®, CYDECTIN® LONG ACTING INJECTION FOR CATTLE, SINGVAC Botulinum vaccines, NITROMEC, MULTIMIN, STRATEGY-T and AQUADENT.

We produce the majority of products sold in Australia at our three local manufacturing sites. Some of our products are exported to the UK, Europe, New Zealand, the Middle East and various Asian countries.

Virbac has been close to its customers and partners from the very beginning. Resolutely focused on meeting their needs, Virbac has developed qualities of flexibility, speed and market sensitivity in order to effectively satisfy its customers and seize new opportunities. Virbac Australia is represented Australia wide by a sales force comprising 43 people, as well as 23 staff in customer service and marketing that service the needs of our customers from head office in Sydney. Virbac products are widely available at most outlets, veterinary clinics, rural or equine supply stores and pet stores.

Know more about Virbac Group
Virbac Group

Virbac Group

With these innovative solutions covering the majority of animal species and diseases, Virbac contributes, day after day, to shape the future of animal health.

Founder

Founder

From a small biology research center established in 1968 in a three-room apartment in Nice to the world’s 7th largest laboratory, a look back at the beginnings of great human adventure.

Values

Values

Nurture entrepreneurship, stimulate innovation, demonstrate our engagement, foster a customer-driven approach, pay attention to people and choose sustainability...

History

1968

1970

1970

1973

1977

1982

1982

1985

1987

1988

1989

1991

1992

1992

1996

1998

1999

1999

2001

2001

2001

2006

2006

2008

2008

2010

2011

2012

2015

2015

2016

2017

2017

2017

1968

PRD.pngCreation of the SARL Virbac biological research center.

1970

1970.pngVirbac starts marketing its products internationally, thanks to distribution partnerships in Benelux and Germany.

1970

COLLIER.pngVirbac develops the first insecticide collar for dogs, which would later become one of the Group’s flagship products.

1973

batiment-construction.pngVirbac constructs the first building of its future headquarters in Carros, near Nice, quickly adding a production and storage unit and a loading dock.

1977

rilexine.pngVirbac offers the first cephalosporin in veterinary medicine (for dogs, cats and cattle), in France, thus providing an alternative to the cephalosporins derived from human pharmaceuticals.

1982

parvovirus.pngIn response to the viral gastroenteritis epidemic decimating dog breeding, Virbac creates the first parvovirus-based vaccine approved for dogs, thus entering the very exclusive club of innovative vaccine-developing laboratories.

1982

filiale-allemagne.pngOpening of the first subsidiary in Germany, following acquisition of local distributor VMG, thus marking the beginning of Virbac’s deployment in Europe.

1985

bourse.pngVirbac, the number-two French animal health laboratory, starts to trade on the secondary market of the Paris stock exchange.

1987

allerderm.pngWith the acquisition of Allerderm Inc., Virbac enters the US market, where it specializes in the new veterinary dermatology market and becomes a global leader a few years later.

1988

leucogen.pngWith the first genetically engineered vaccine against feline leukemia made from a purified p45 FeLV-envelope retrovirus, Virbac provides veterinarians with an effective solution against a disease in cats for which there was no cure at the time.

1989

imperial-dog.pngVirbac acquires Imperial Dog, a dog and cat food manufacturer, founded by the creator of Royal Canin, now Virbac Nutrition.

1991

vaccin-renard.pngIn Europe, Virbac offers the first oral anti-rabies vaccine for foxes, obtained by selective mutation.

1992

PRD-JD.pngVeterinarian doctor Pierre-Richard Dick, founder of Virbac, dies suddenly at the age of 55 while on a Central American sea voyage. Pascal Boissy, then financial director, succeeds him to head the company. Six months later, the company adopts a new organizational structure made up of an executive board and a supervisory board, of which Jeanine Dick, wife of the founder, become chairwoman.

1992

asie.pngVirbac continues its international expansion with the creation of its first subsidiary in Asia (a partnership with Maruyasu, a Japanese import-export company).

1996

fusion.pngNumerous companies created to develop the company on French territory merge into a single subsidiary, Virbac France, formalizing the beginning of the Virbac umbrella brand.

1998

jelaime,jelevaccine.pngThrough its “I love my pet, I vaccinate it” poster campaign, Virbac raises the general public’s awareness of vaccination in France.

1999

EM.pngEric Marée, 48 years old, graduate of HEC and holder of an MBA from Cornell University in the United States, becomes chairman of the Virbac executive board.

1999

stlouis.pngThanks to the acquisition of Agri-Nutrition, a company based in St. Louis (Missouri), Virbac acquires a range of dental care and hygiene products.

2001

virbagen-omega.pngVirbac offers veterinarians the first interferon omega for dogs and cats in Europe.

2001

fondation2001.pngThe Pierre-Richard Dick Foundation, created in 1993 after the founder’s death, becomes the Virbac Corporate Foundation. Chaired by his son, Jean-Pierre Dick, it aims to raise public awareness, educate and inform, especially children, about issues related to the integration and well-being of animals in cities.

2001

JPdick.pngVirbac joins Jean-Pierre Dick, son of the founder and doctor of veterinary medicine, on his sailing adventure: through his involvement in epic races, the skipper helps to enhance the veterinary profession and promote animal health.

2006

MHDick.pngMarie-Hélène Dick, daughter of the founder, veterinary doctor and MBA graduate from HEC, is named chairwoman of Virbac’s supervisory board.

2006

inde.pngVirbac becomes number one in India through the acquisition of Agrivet Farm Care, the animal health branch of GlaxoSmithKline.

2008

prod.pngWith 7 production units, Virbac currently has an industrial park on all five continents (France, United States, Mexico, Brazil, Australia, South Africa and Vietnam).

2008

suprelorin.pngVirbac offers veterinarians the first deslorelin-based implant for the induction of temporary infertility in male dogs.

2010

australie.pngVirbac signs an agreement with Pfizer Inc. to acquire the Australian rights to a range of products for food producing animals, primarily parasiticides and vaccines for cattle and sheep.

2011

canileish.pngVirbac launches the first vaccine against canine leishmaniasis in Europe.

2012

aqua.pngVirbac acquires a majority share of Centrovet, animal health market leader in Chile, expert in the development and production of innovative products for the protection and treatment of cold water aquaculture farms (salmon and trout).

2015

cochon.pngVirbac acquires Schweitzer Biotech Company, a Taiwanese company that is an expert in the development of cell culture banks serving as the basis for production of viral vaccines primarily for swine and poultry. This acquisition formalizes the creation of a new biology R&D structure in Southeast Asia, a region recognized for the largest swine and aquaculture (warm water) markets on the planet.

2015

fondation.pngThe Virbac Corporate Foundation, aware of the challenges related to the interconnection between animal, human, and environmental health, initiates support for a screening, control, and prevention program for bovine tuberculosis and rabies in the Gonarezhou Park (Zimbabwe).

2016

argonavis.pngAfter the construction of VB8 in Carros in 2014, a production building dedicated to the manufacture of sterile injectables, Virbac continues to invest in quality and to strengthen its production capacities with Argo Navis, VB8’s alter ego in Mexico.

2017

petfood.pngAfter the physiological range in 2016, Virbac launches a range of dietetic petfood for dogs and cats. Their composition is particularly suited to the dietary needs of carnivores.

2017

voile.pngAt the helm of St. Michel-Virbac, Jean-Pierre Dick wins his fourth Jacques Vabre Race (a first in the history of the Coffee Race). This victory marks a turning point in the life of the sailor and the most fitting closure to his 17 years of adventures around the world, flying Virbac’s colors.

2017

SH.pngSébastien Huron, 47 years old, doctor of veterinary medicine, head of Global Business Operations, and member of the executive board since 2012, succeeds Éric Marée as chairman of Virbac.

Legal notice
All medicines or products mentioned in this document can be not authorized or not marketed in all the countries including France. The product names stated in this document are subject to protection in particular in respect of trademarks. Virbac and/or its subsidiaries are the owners or have exclusive use of them.